Author:
Grafeneder Juergen,Ettl Florian,Warenits Alexandra-Maria,Buchtele Nina,Lobmeyr Elisabeth,Staudinger Thomas,Schwameis Michael,Sperr Wolfgang R.,Gelbenegger Georg,Schoergenhofer Christian,Jilma Bernd
Abstract
We present a case of a 52-year-old patient suffering from multi-phasic life-threatening anaphylaxis refractory to epinephrine treatment. Extracorporeal membrane oxygenation (ECMO) therapy was initiated as the ultima ratio to stabilize the patient hemodynamically during episodic severe bronchospasm. ECMO treatment was successfully weaned after 4 days. Mastocytosis was diagnosed as the underlying condition. Although epinephrine is recommended as a first-line treatment for anaphylaxis, this impressive case provides clear evidence of its limited therapeutic success and emphasizes the need for causal therapies.
Subject
General Earth and Planetary Sciences
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献